Louise Vrancken
Liege, WAL, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: From spheroids to organoids: next-generation models for CAR-T cell therapy research in solid tumors.
Journal: Frontiers in immunology
Published: November 03, 2025
From spheroids to organoids: next-generation models for CAR-T cell therapy research in solid tumors.
From spheroids to organoids: next-generation models for CAR-T cell therapy research in solid tumors.
Journal: Frontiers in immunology
Published: May 10, 2025
Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
Journal: Journal of hematology & oncology
Published: April 07, 2022
Radiotheranostic Agents in Hematological Malignancies.
Journal: Frontiers in immunology
Published: April 01, 2022
Multiple myeloma : an overview of advances in biology and treatment
Journal: Revue medicale de Liege
Published: June 03, 2021
The anti-mitotic agents PTC-028 and PTC596 display potent activity in pre-clinical models of multiple myeloma but challenge the role of BMI-1 as an essential tumour gene.
Journal: British journal of haematology
Published: October 03, 2019
What is new in the management of multiple myeloma
Journal: Revue medicale suisse
Published: August 24, 2018
In Vitro Th17-Polarized Human CD4+ T Cells Exacerbate Xenogeneic Graft-versus-Host Disease.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: August 05, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026